» Articles » PMID: 24562983

Supratentorial Ependymomas of Childhood Carry C11orf95-RELA Fusions Leading to Pathological Activation of the NF-κB Signaling Pathway

Overview
Specialty Neurology
Date 2014 Feb 25
PMID 24562983
Citations 62
Authors
Affiliations
Soon will be listed here.
Citing Articles

Advances in molecular prognostication and treatments in ependymoma.

Bakes E, Cheng R, Manucat-Tan N, Ramaswamy V, Hansford J J Neurooncol. 2025; .

PMID: 39757304 DOI: 10.1007/s11060-024-04923-9.


Metabolism: an important player in glioma survival and development.

Wang N, Yuan Y, Hu T, Xu H, Piao H Discov Oncol. 2024; 15(1):577.

PMID: 39436434 PMC: 11496451. DOI: 10.1007/s12672-024-01402-5.


Novel case of ependymoma-like tumor with mesenchymal differentiation harboring ZFTA::RELA fusion in an adult.

Yajima H, Takayanagi S, Takami H, Tanaka S, Nomura M, Satomi K Brain Tumor Pathol. 2024; 41(3-4):139-144.

PMID: 39244726 DOI: 10.1007/s10014-024-00489-6.


Supra-tentorial Ependymomas with ZFTA Fusion, YAP1 Fusion, and Astroblastomas, MN1-altered: Characteristic Imaging Features.

Perrod V, Levy R, Tauziede-Espariat A, Roux C, Beccaria K, Blauwblomme T Clin Neuroradiol. 2024; 34(4):939-950.

PMID: 39093426 DOI: 10.1007/s00062-024-01444-w.


: NF-κB Inhibition as an Alternative to Overcome Osteosarcoma Heterogeneity.

Medeiros M, Guenka S, Bastos D, Oliveira K, Brassesco M Pharmaceuticals (Basel). 2024; 17(6).

PMID: 38931401 PMC: 11206879. DOI: 10.3390/ph17060734.